ALDX R&D Expenses
Aldeyra Therapeutics Inc · R&D Expenses
ALDX R&D Expenses
Latest reported$15.63Mperiod ending
ALDX TTM R&D Expenses ($1.54M → $15.63M)
TTM R&D Expenses
High-resolution chart · PNG
ALDX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 15,628,392 | |
| 20,649,107 | |
| 25,662,856 | |
| 35,989,342 | |
| 43,000,094 | |
| 49,464,608 | |
| 48,224,792 | |
| 37,893,042 | |
| 32,413,202 | |
| 24,406,366 | |
| 29,458,719 | |
| 34,121,909 | |
| 38,699,860 | |
| 46,307,607 | |
| 47,306,066 | |
| 51,185,994 | |
| 52,540,718 | |
| 49,444,510 | |
| 44,936,532 | |
| 39,123,375 | |
| 32,362,611 | |
| 25,774,040 | |
| 24,681,301 | |
| 27,267,489 | |
| 37,357,881 | |
| 43,136,864 | |
| 44,351,851 | |
| 43,286,395 | |
| 34,943,245 | |
| 31,071,361 | |
| 29,822,877 | |
| 26,819,191 | |
| 22,477,737 | |
| 19,533,652 | |
| 16,302,569 | |
| 14,204,456 | |
| 14,044,799 | |
| 13,030,433 | |
| 13,172,887 | |
| 12,838,168 | |
| 11,534,867 | |
| 9,949,441 | |
| 7,574,398 | |
| 5,865,631 | |
| 4,984,889 | |
| 4,399,700 | |
| 3,707,544 | |
| 2,704,212 | |
| 2,174,584 | |
| 1,835,726 | |
| 1,541,681 | |
| 1,237,490 |